Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sotera Health (SHC) Cash from Operations (2020 - 2025)

Historic Cash from Operations for Sotera Health (SHC) over the last 6 years, with Q3 2025 value amounting to $71.2 million.

  • Sotera Health's Cash from Operations fell 2698.63% to $71.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $239.8 million, marking a year-over-year decrease of 1483.18%. This contributed to the annual value of $224.2 million for FY2024, which is 25173.69% up from last year.
  • Per Sotera Health's latest filing, its Cash from Operations stood at $71.2 million for Q3 2025, which was down 2698.63% from $57.4 million recorded in Q2 2025.
  • In the past 5 years, Sotera Health's Cash from Operations ranged from a high of $113.1 million in Q4 2023 and a low of -$336.6 million during Q2 2023
  • Moreover, its 5-year median value for Cash from Operations was $58.3 million (2022), whereas its average is $43.2 million.
  • In the last 5 years, Sotera Health's Cash from Operations skyrocketed by 88697.72% in 2021 and then tumbled by 67742.46% in 2023.
  • Over the past 5 years, Sotera Health's Cash from Operations (Quarter) stood at $66.4 million in 2021, then skyrocketed by 53.62% to $101.9 million in 2022, then increased by 10.99% to $113.1 million in 2023, then tumbled by 50.75% to $55.7 million in 2024, then increased by 27.71% to $71.2 million in 2025.
  • Its last three reported values are $71.2 million in Q3 2025, $57.4 million for Q2 2025, and $55.5 million during Q1 2025.